Finance

Beta
Lists
PMN:NASDAQ
Promis Neurosciences Inc
US$ १३.७८
+१.७०%
(+०.२३) 1D
जुलाई ८, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMN...
Open
US$ १३.८२
High
US$ १३.९६
Low
US$ १३.४१
Mkt. cap
१२.३६ करोड
Avg. vol.
३४.९३ हजार
Volume
६७.३० हजार
52-wk high
US$ ३९.७५
52-wk low
US$ ६.२७
EPS
-US$ १८.५९
Beta
-०.१९
Shares outstanding
८९.६८ लाख
No. of employees
११
Open
US$ १३.८२
High
US$ १३.९६
Low
US$ १३.४१
Mkt. cap
१२.३६ करोड
Avg. vol.
३४.९३ हजार
Volume
६७.३० हजार
52-wk high
US$ ३९.७५
52-wk low
US$ ६.२७
EPS
-US$ १८.५९
Beta
-०.१९
Shares outstanding
८९.६८ लाख
No. of employees
११
News stories
From sources across the web
https://www.dars.gov.et/
https://www.dars.gov.et/
·
३ हप्ता पहिले
PMN Q1 2026 Earnings: Narrowing Losses Amidst Clinical Progress - Earnings Revision Upgrade
About Promis Neurosciences Inc
CEO-
Employees११
Founded२००५
Headquartersमिसिससाउगा, ओन्टारियो, क्यानाडा
Sector-
Websitepromisneurosciences.com
Analyst ratings
Based on 6 analysts giving stock ratings to PMN in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PMN in the last 3 months.
Highest
Current US$ १३.७८
US$ ४०.०० (+१९०.२८%)
Average
US$ ३१.१३ (+१२५.९१%)
Lowest
US$ १८.०० (+३०.६२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Initiated
US$ १९.००
+३७.९%
07/08/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
US$ ३९.७५
+१८८.५%
06/29/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ १८.००
+३०.६%
06/25/2026
Unknown Analyst
Brookline Capital Markets
Buy
Initiated
US$ ४०.००
+१९०.३%
05/20/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
US$ ३५.००
+१५४%
05/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ३५.००
+१५४%
05/14/2026
Eddie Hickman
Guggenheim
Buy
Maintained
US$ ३५.००
+१५४%
02/05/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
-
-
-
-
Cost of goods sold
८७.५० लाख
९७.९७ लाख
९३.६८ लाख
-
Cost of revenue
८७.५० लाख
९७.९७ लाख
९३.६८ लाख
-
Research and development expenses
-
-
-
६९.७१ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१४.३५ लाख
१९.५३ लाख
१४.०४ लाख
१६.७४ लाख
Operating expense
१४.३५ लाख
१९.५३ लाख
१४.०४ लाख
८६.४५ लाख
Total operating expenses
१.०२ करोड
१.१८ करोड
१.०८ करोड
८६.४५ लाख
Operating income
-१.०२ करोड
-१.१८ करोड
-१.०८ करोड
-८६.४५ लाख
Other non operating income
६७.६३ हजार
१.७० लाख
९८.०३ हजार
४.०१ लाख
EBT including unusual items
-१.०१ करोड
-१.१६ करोड
-१.०७ करोड
-८२.४४ लाख
EBT excluding unusual items
-१.०१ करोड
-१.१६ करोड
-१.०७ करोड
-८२.४४ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.०१ करोड
-१.१६ करोड
-१.०७ करोड
-८२.४४ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer